Status: Recruiting
Behavioral Pharmacology of Orally Administered THC and D-limonene
The current clinical trial will investigate the effects of orally administered d-limonene (limonene), delta-9-tetrahydrocannabinol (THC) and the combination in healthy adult volunteers.
Participants needed: 65
Trial details
Phase: Phase 1Age: 21-55Biological sex: AllType: InterventionalSponsor: Johns Hopkins UniversityUpdated: May 28, 2026Locations: 1
Eligibility criteria
Have provided written informed consent [+8]
Non-medical use of psychoactive drugs other than, nicotine, alcohol, or caffeine... [+7]